Identifying optimal flow rates for airway eosinophilia detection in asthma

Area of Science:

• Pulmonology
• Biomarkers
• Asthma Research

Background:

• Fractional exhaled nitric oxide (FeNO) is a key biomarker for eosinophilic airway inflammation.
• The accuracy of FeNO measurements is significantly influenced by the expiratory flow rate used.
• Identifying optimal flow rates is crucial for reliable FeNO assessment in clinical practice.

Purpose of the Study:

• To determine the most effective expiratory flow rates for fractional exhaled nitric oxide (FeNO) measurements in diagnosing asthma-related airway inflammation.
• To compare the diagnostic performance of different FeNO flow rates (45, 50, 55, and 200 mL/s) in identifying eosinophilic airway inflammation.

Main Methods:

• Prospective cohort study involving 18 healthy controls and 61 adult asthmatics.
• Measurements included FeNO at various flow rates (45, 50, 55, 200 mL/s), complete blood counts, sputum cytology, and spirometry.
• Correlations between FeNO levels and sputum/peripheral eosinophils were analyzed using ROC curves.

Main Results:

• FeNO at 50 mL/s (FeNO50) showed the strongest correlation with peripheral eosinophils (r=0.51).
• FeNO at 200 mL/s (FeNO200) demonstrated superior predictive accuracy for sputum eosinophilia (AUC up to 0.743).
• Combining FeNO200 with peripheral eosinophil counts significantly enhanced diagnostic accuracy (AUC up to 0.806).

Conclusions:

• Controlling expiratory flow rate at 50 mL/s optimizes FeNO correlation with eosinophil counts.
• FeNO measurement at 200 mL/s provides superior diagnostic performance for airway eosinophilic inflammation.
• A combined approach using FeNO200 and peripheral eosinophil counts offers a robust diagnostic strategy for asthma.